Author:
Stephenson Diane,Aviles Enrique,Bain Lisa J.,Brumfield Martha,Carrillo Maria,Comery Thomas A.,Compton Carolyn,Corrigan Brian,Gordon Mark Forrest,Jack Clifford R.,Katz Russell,Logovinsky Veronika,Satlin Andrew,Marek Ken,Nicholas Timothy,Polhamus Dan,Angersbach B. Steven,Raghavan Nandini,Romano Gary,Romero Klaus,Shaw Leslie,Woodcock Janet,Vradenburg George,Isaac Maria
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Public Health, Environmental and Occupational Health,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Reference29 articles.
1. Food and Drug Administration. Innovation or stagnation: challenges and opportunity on the critical path to new medical products. http://www.fda.gov/downloads/ScienceResearch/SpecialTopics/CriticalPathInitiative/CriticalPathOpportunitiesReports/ucm113411.pdf. Accessed February 26, 2013.
2. Romero K, Corrigan B, Neville J, Kopko S, Cantillon M. Striving for an integrated drug development process for neurodegeneration: the coalition against major diseases. Neurodegen Dis Manage. 2011;1(5):1–7.
3. Jonsson T, Atwal JK, Steinberg S, et al. A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline. Nature. 2012;488(7409):96–99.
4. Sproul A, Jacob S, Nestor M, et al. Development of an induced pluripotent stem cell (iPSC) Alzheimer’s disease model using PSEN1 mutant fibroblasts. Alzheimers Dement. 2012;8(4 suppl):P724.
5. Sperling R, Salloway S, Honig LS, et al. A randomized, double-blind, placebo-controlled clinical trial of intravenous bapineuzumab in patients who are apolipoprotein E e4 non-carriers. Eur J Neurol. 2012;19(suppl 1):70.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献